Quantum Biopharma Ltd (QNTM)

$7.64 +0.59 (8.37%)
Market Cap 35.27M
Revenue (ttm) 0.00
Net Income (ttm) -26.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 550,400
Avg Vol 531,992
Day's Range N/A - N/A
Shares Out 3.82M
Stochastic %K 34%
Beta 0.29
Analysts Sell
Price Target $35.50

Company Profile

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company's lead compound is Lucid-MS, a patented new chemical enti...

Industry: Biotechnology
Sector: Healthcare
Phone: 833 571 1811
Address:
1 Adelaide Street East, Suite 801, Toronto, Canada
TomTamo
TomTamo May. 27 at 9:15 PM
$QNTM 🥱 prenarket yesterday I thought damn we are in for a week… guess not
0 · Reply
Smartacusnot
Smartacusnot May. 27 at 8:21 PM
$QNTM
0 · Reply
jpoptions
jpoptions May. 27 at 5:52 PM
$QNTM Didn't sell yesterday. GLTA
0 · Reply
GPDL
GPDL May. 27 at 5:15 PM
$QNTM Must keep picking away, I want so many shares
0 · Reply
FickleFin
FickleFin May. 27 at 11:31 AM
$QNTM 🥴
1 · Reply
BleedinJaysus
BleedinJaysus May. 27 at 2:14 AM
$QNTM irresistible at these levels for a swing unless something horrendous has just occurred and we are yet to hear the news. We are but gamblers, we are but men.
1 · Reply
PivotalSaints
PivotalSaints May. 26 at 10:01 PM
$QNTM Good to see you old friend Shall we have tea? 🫖 你喜欢恰我喜欢宁夏
0 · Reply
PivotalSaints
PivotalSaints May. 26 at 9:59 PM
$QNTM Ok
0 · Reply
ShadowSnake
ShadowSnake May. 26 at 9:56 PM
$QNTM why is this filling the quantum index? It’s a biotech company… 🤦‍♂️
0 · Reply
Ginelle2424
Ginelle2424 May. 26 at 8:40 PM
$QNTM that was spicy, time to buy more
0 · Reply
Latest News on QNTM
Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with Massachusetts General Hospital

Mon, 18 May 2026 03:00:00 -0400 - 9 days ago

Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with Massachusetts General Hospital

Quantum Reports Strengthened Liquidity, Reduced Cash Burn, and Disciplined Cost Management in First Quarter 2026

Thu, 07 May 2026 07:00:00 -0400 - 20 days ago

Quantum Reports Strengthened Liquidity, Reduced Cash Burn, and Disciplined Cost Management in First Quarter 2026

Quantum BioPharma Provides Corporate Update

Mon, 27 Apr 2026 19:45:00 -0400 - 4 weeks ago

Quantum BioPharma Provides Corporate Update

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant

Wed, 22 Apr 2026 09:16:00 -0400 - 5 weeks ago

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant

Quantum BioPharma submits Lucid-21-302 new drug application to the FDA

2026-04-01T12:25:14.000Z - 2 months ago

Quantum BioPharma submits Lucid-21-302 new drug application to the FDA

Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis

Wed, 01 Apr 2026 08:02:00 -0400 - 2 months ago

Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis

Quantum BioPharma signs letter of intent with Allucent to conduct Lucid-MS trial

2026-03-30T12:47:57.000Z - 2 months ago

Quantum BioPharma signs letter of intent with Allucent to conduct Lucid-MS trial

Quantum BioPharma signs letter of intent with Allucent to conduct Lucid-MS trial

2026-03-30T12:28:19.000Z - 2 months ago

Quantum BioPharma signs letter of intent with Allucent to conduct Lucid-MS trial

Quantum BioPharma Signs Binding Letter Of Intent With Allucent To Conduct Phase 2 Clinical Trial In Multiple Sclerosis

Mon, 30 Mar 2026 07:50:00 -0400 - 2 months ago

Quantum BioPharma Signs Binding Letter Of Intent With Allucent To Conduct Phase 2 Clinical Trial In Multiple Sclerosis

Quantum Biopharma Provides Corporate Update

Fri, 27 Mar 2026 19:30:00 -0400 - 2 months ago

Quantum Biopharma Provides Corporate Update

Quantum Biopharma's 2025 Audited Year End Financial Results Maintain ‘No Going Concern' Status

Fri, 27 Mar 2026 08:10:00 -0400 - 2 months ago

Quantum Biopharma's 2025 Audited Year End Financial Results Maintain ‘No Going Concern' Status

Quantum BioPharma Announces Peer-Reviewed Journal Publication of Groundbreaking Clinical Trial With Unbuzzd

Mon, 23 Mar 2026 08:24:00 -0400 - 2 months ago

Quantum BioPharma Announces Peer-Reviewed Journal Publication of Groundbreaking Clinical Trial With Unbuzzd

Quantum Biopharma Announces Closing of Initial Tranche of Private Placement Offering

Fri, 20 Mar 2026 19:35:00 -0400 - 2 months ago

Quantum Biopharma Announces Closing of Initial Tranche of Private Placement Offering

Quantum BioPharma Provides Corporate Update

Wed, 11 Mar 2026 19:55:00 -0400 - 2 months ago

Quantum BioPharma Provides Corporate Update

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM

Thu, 19 Feb 2026 19:29:00 -0500 - 3 months ago

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM

Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

Thu, 19 Feb 2026 12:00:00 -0500 - 3 months ago

Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

Portnoy Law Firm Announces Class Action on Behalf of Quantum Biopharma, Ltd. Investors

Tue, 17 Feb 2026 13:55:00 -0500 - 3 months ago

Portnoy Law Firm Announces Class Action on Behalf of Quantum Biopharma, Ltd. Investors

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM

Tue, 17 Feb 2026 12:59:00 -0500 - 3 months ago

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM

Portnoy Law Firm Announces Class Action on Behalf of Quantum Corporation Investors

Tue, 17 Feb 2026 09:41:00 -0500 - 3 months ago

Portnoy Law Firm Announces Class Action on Behalf of Quantum Corporation Investors

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM

Thu, 12 Feb 2026 16:02:00 -0500 - 3 months ago

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM

Tue, 03 Feb 2026 13:12:00 -0500 - 4 months ago

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM

Portnoy Law Firm Announces Class Action on Behalf of Quantum Biopharma Ltd. Investors

Mon, 02 Feb 2026 10:46:00 -0500 - 4 months ago

Portnoy Law Firm Announces Class Action on Behalf of Quantum Biopharma Ltd. Investors

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM

Tue, 27 Jan 2026 13:42:00 -0500 - 4 months ago

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM

Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS)

Dec 23, 2025, 8:00 AM EST - 5 months ago

Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS)

World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares

Mon, 22 Dec 2025 09:00:00 -0500 - 5 months ago

World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares

Quantum BioPharma Announces Closing of Private Placement & Provides Corporate Update

Dec 10, 2025, 8:00 PM EST - 5 months ago

Quantum BioPharma Announces Closing of Private Placement & Provides Corporate Update

Quantum BioPharma announces airing of news segment on manipulation lawsuit

2025-12-01T12:15:18.000Z - 6 months ago

Quantum BioPharma announces airing of news segment on manipulation lawsuit

Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada's Largest Banks, CIBC and RBC

Nov 27, 2025, 4:00 PM EST - 6 months ago

Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada's Largest Banks, CIBC and RBC

Quantum Biopharma's USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5

Nov 26, 2025, 9:30 AM EST - 6 months ago

Quantum Biopharma's USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5

Quantum BioPharma reports Q3 EPS ($1.25) vs. (4.37) last year

2025-11-07T12:12:42.000Z - 7 months ago

Quantum BioPharma reports Q3 EPS ($1.25) vs. (4.37) last year

Quantum BioPharma sees cash runway beyond March 2027

2025-11-07T12:11:35.000Z - 7 months ago

Quantum BioPharma sees cash runway beyond March 2027

Quantum Biopharma Reports Strong Third Quarter Results Maintaining ‘No Going Concern' Status with Cash Runway Extending Beyond March 2027, and $572,000 USD Gains in Crypto Portfolio

Nov 7, 2025, 7:00 AM EST - 7 months ago

Quantum Biopharma Reports Strong Third Quarter Results Maintaining ‘No Going Concern' Status with Cash Runway Extending Beyond March 2027, and $572,000 USD Gains in Crypto Portfolio

Quantum BioPharma Ltd. Provides Corporate Update

Oct 31, 2025, 7:51 PM EDT - 7 months ago

Quantum BioPharma Ltd. Provides Corporate Update

Quantum BioPharma Ltd. Announces Corporate Updates

Oct 29, 2025, 9:00 PM EDT - 7 months ago

Quantum BioPharma Ltd. Announces Corporate Updates

Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar for its Disruptive Beverage Innovation that Speeds Alcohol Metabolism, Reduces Symptoms of Intoxication

Oct 23, 2025, 8:15 AM EDT - 7 months ago

Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar for its Disruptive Beverage Innovation that Speeds Alcohol Metabolism, Reduces Symptoms of Intoxication

Quantum BioPharma announces expiration of warrants held by hedge funds

2025-10-20T12:40:40.000Z - 7 months ago

Quantum BioPharma announces expiration of warrants held by hedge funds

Quantum BioPharma Ltd. Announces Expiration of All Warrants Held by Hedge Funds and Re-Iterates October 27, 2025, Record Date for the Distribution of a Special Dividend

Oct 20, 2025, 8:30 AM EDT - 7 months ago

Quantum BioPharma Ltd. Announces Expiration of All Warrants Held by Hedge Funds and Re-Iterates October 27, 2025, Record Date for the Distribution of a Special Dividend

Quantum BioPharma Ltd. Responds to Vague and Misleading Allegations by The Schall Law Firm and DJS Law Group

Oct 14, 2025, 8:15 AM EDT - 8 months ago

Quantum BioPharma Ltd. Responds to Vague and Misleading Allegations by The Schall Law Firm and DJS Law Group

Quantum BioPharma Ltd. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – QNTM

Oct 9, 2025, 6:00 PM EDT - 8 months ago

Quantum BioPharma Ltd. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – QNTM

QNTM Investors Have Opportunity to Join Quantum BioPharma Ltd. Fraud Investigation with the Schall Law Firm

Oct 9, 2025, 5:40 PM EDT - 8 months ago

QNTM Investors Have Opportunity to Join Quantum BioPharma Ltd. Fraud Investigation with the Schall Law Firm

Quantum BioPharma offers cash reward up to $7M for market manipulation proof

2025-10-08T12:15:28.000Z - 8 months ago

Quantum BioPharma offers cash reward up to $7M for market manipulation proof

Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock

Oct 8, 2025, 8:00 AM EDT - 8 months ago

Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock

Quantum BioPharma: Engineering the Digital Balance Sheet in Life Sciences A Vanderbilt Report View

Oct 7, 2025, 11:00 AM EDT - 8 months ago

Quantum BioPharma: Engineering the Digital Balance Sheet in Life Sciences A Vanderbilt Report View

Quantum BioPharma announces record date for special dividend distribution

2025-10-03T11:10:25.000Z - 8 months ago

Quantum BioPharma announces record date for special dividend distribution

Quantum BioPharma Announces the Record Date for the Distribution of a Special Dividend of Contingent Value Rights (CVRs) Tied to the Future Litigation Settlement Proceeds of its USD $700 Million+ Case

Oct 3, 2025, 7:00 AM EDT - 8 months ago

Quantum BioPharma Announces the Record Date for the Distribution of a Special Dividend of Contingent Value Rights (CVRs) Tied to the Future Litigation Settlement Proceeds of its USD $700 Million+ Case

Quantum BioPharma receives final reports for two studies of Lucid-21-302

2025-10-02T12:00:38.000Z - 8 months ago

Quantum BioPharma receives final reports for two studies of Lucid-21-302

Quantum BioPharma Receives Final Reports for Two Key Studies of its Potential Breakthrough Drug for Multiple Sclerosis, Moving Closer to Phase 2 Clinical Trial

Oct 2, 2025, 7:57 AM EDT - 8 months ago

Quantum BioPharma Receives Final Reports for Two Key Studies of its Potential Breakthrough Drug for Multiple Sclerosis, Moving Closer to Phase 2 Clinical Trial

Quantum BioPharma appoints Jack Antel as clinical development advisor

2025-10-01T11:55:37.000Z - 8 months ago

Quantum BioPharma appoints Jack Antel as clinical development advisor

Quantum BioPharma Welcomes World-Renowned Multiple Sclerosis Expert Dr. Jack Antel as Clinical Development Advisor For Lucid-MS Trials

Oct 1, 2025, 7:50 AM EDT - 8 months ago

Quantum BioPharma Welcomes World-Renowned Multiple Sclerosis Expert Dr. Jack Antel as Clinical Development Advisor For Lucid-MS Trials

Quantum BioPharma announces Annual General, Special Meeting results

2025-09-29T11:45:06.000Z - 8 months ago

Quantum BioPharma announces Annual General, Special Meeting results

Quantum BioPharma Ltd. Announces Results of Annual General and Special Meeting of Shareholders

Sep 29, 2025, 7:40 AM EDT - 8 months ago

Quantum BioPharma Ltd. Announces Results of Annual General and Special Meeting of Shareholders

Quantum BioPharma Announces Corporate Updates

Sep 26, 2025, 8:00 PM EDT - 8 months ago

Quantum BioPharma Announces Corporate Updates

Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar and Q&A Session on Wednesday, October 1, 2025

Sep 24, 2025, 8:30 AM EDT - 8 months ago

Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar and Q&A Session on Wednesday, October 1, 2025

Health Canada Grants Quantum BioPharma a Product License for Its Innovative Product, Qlarity™, that Enhances Energy, and Promotes Metabolism, Mental Alertness and Cognitive Performance

Sep 18, 2025, 8:10 AM EDT - 8 months ago

Health Canada Grants Quantum BioPharma a Product License for Its Innovative Product, Qlarity™, that Enhances Energy, and Promotes Metabolism, Mental Alertness and Cognitive Performance

Quantum BioPharma Licensee Unbuzzd Wellness to Host Investor Webinar on September 16, 2025 at 1:30 PM PT

Sep 12, 2025, 7:50 AM EDT - 9 months ago

Quantum BioPharma Licensee Unbuzzd Wellness to Host Investor Webinar on September 16, 2025 at 1:30 PM PT

Kingswood Capital Partners Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$45 Price Target

Sep 10, 2025, 7:00 AM EDT - 9 months ago

Kingswood Capital Partners Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$45 Price Target

Quantum BioPharma Announces Update to Previously Announced Private Placement

Aug 11, 2025, 6:32 PM EDT - 10 months ago

Quantum BioPharma Announces Update to Previously Announced Private Placement

Quantum BioPharma Signs Agreement to Manufacture Oral Drug Formulation of its Potential Breakthrough Drug Lucid-21-302 (Lucid-MS) for Use in its Upcoming Phase 2 Multiple Sclerosis Trial

Aug 11, 2025, 7:40 AM EDT - 10 months ago

Quantum BioPharma Signs Agreement to Manufacture Oral Drug Formulation of its Potential Breakthrough Drug Lucid-21-302 (Lucid-MS) for Use in its Upcoming Phase 2 Multiple Sclerosis Trial

Quantum BioPharma announces results from study on PET tracer

2025-08-08T12:10:18.000Z - 10 months ago

Quantum BioPharma announces results from study on PET tracer

Quantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in Multiple Sclerosis Patients

Aug 8, 2025, 8:00 AM EDT - 10 months ago

Quantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in Multiple Sclerosis Patients

Quantum Biopharma Reports Strong Second Quarter with Increased Current and Total Assets, Conversion of all Debentures into Equity, Continued Exclusion of Going Concern, Tripling of Share Price during Quarter, over $500,000 USD Gain in Crypto Assets as of date of filing, and Near Elimination of Debt

Aug 7, 2025, 7:00 AM EDT - 10 months ago

Quantum Biopharma Reports Strong Second Quarter with Increased Current and Total Assets, Conversion of all Debentures into Equity, Continued Exclusion of Going Concern, Tripling of Share Price during Quarter, over $500,000 USD Gain in Crypto Assets as of date of filing, and Near Elimination of Debt

Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid-MS)

Aug 5, 2025, 7:34 AM EDT - 10 months ago

Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid-MS)

Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/Spoofing

Aug 4, 2025, 7:33 AM EDT - 10 months ago

Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/Spoofing

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Commences Reg D Capital Raise Campaign to Fund Growth and Possible IPO

Jul 31, 2025, 7:24 AM EDT - 10 months ago

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Commences Reg D Capital Raise Campaign to Fund Growth and Possible IPO

Quantum BioPharma Makes Strategic Investment in GameStop Corp.

Jul 22, 2025, 7:00 AM EDT - 11 months ago

Quantum BioPharma Makes Strategic Investment in GameStop Corp.

GME

Quantum BioPharma Announces Private Placement

Jun 27, 2025, 4:30 PM EDT - 11 months ago

Quantum BioPharma Announces Private Placement

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering

Jun 26, 2025, 7:30 AM EDT - 11 months ago

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering

Singular Research Reports on Quantum BioPharma Ltd.'s Strategic Advances and Pipeline Progress

Jun 18, 2025, 9:19 AM EDT - 1 year ago

Singular Research Reports on Quantum BioPharma Ltd.'s Strategic Advances and Pipeline Progress

Quantum BioPharma Announces First Person with Multiple Sclerosis (MS) Scanned in Joint Study with Massachusetts General Hospital

Jun 17, 2025, 8:00 AM EDT - 1 year ago

Quantum BioPharma Announces First Person with Multiple Sclerosis (MS) Scanned in Joint Study with Massachusetts General Hospital

Quantum BioPharma Announces Intention to Declare Special Dividend of Contingent Value Rights (CVRs) Linked to Future Litigation Settlement Proceeds

Jun 13, 2025, 7:00 AM EDT - 1 year ago

Quantum BioPharma Announces Intention to Declare Special Dividend of Contingent Value Rights (CVRs) Linked to Future Litigation Settlement Proceeds

Quantum BioPharma Clarifies It Has Not Changed Its Name

Jun 3, 2025, 7:50 AM EDT - 1 year ago

Quantum BioPharma Clarifies It Has Not Changed Its Name

iNGENū CRO Partners with Quantum BioPharma to Launch Pioneering Australian Clinical Trial for Chronic Nociplastic Pain in MCAS Patients

Jun 2, 2025, 1:47 PM EDT - 1 year ago

iNGENū CRO Partners with Quantum BioPharma to Launch Pioneering Australian Clinical Trial for Chronic Nociplastic Pain in MCAS Patients

Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari

May 30, 2025, 7:00 AM EDT - 1 year ago

Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari

Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit Firm MNP LLP to Advance Capital Raise and Go-Public Readiness and Changes Name To Unbuzzd Wellness Inc.

May 29, 2025, 7:30 AM EDT - 1 year ago

Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit Firm MNP LLP to Advance Capital Raise and Go-Public Readiness and Changes Name To Unbuzzd Wellness Inc.

TomTamo
TomTamo May. 27 at 9:15 PM
$QNTM 🥱 prenarket yesterday I thought damn we are in for a week… guess not
0 · Reply
Smartacusnot
Smartacusnot May. 27 at 8:21 PM
$QNTM
0 · Reply
jpoptions
jpoptions May. 27 at 5:52 PM
$QNTM Didn't sell yesterday. GLTA
0 · Reply
GPDL
GPDL May. 27 at 5:15 PM
$QNTM Must keep picking away, I want so many shares
0 · Reply
FickleFin
FickleFin May. 27 at 11:31 AM
$QNTM 🥴
1 · Reply
BleedinJaysus
BleedinJaysus May. 27 at 2:14 AM
$QNTM irresistible at these levels for a swing unless something horrendous has just occurred and we are yet to hear the news. We are but gamblers, we are but men.
1 · Reply
PivotalSaints
PivotalSaints May. 26 at 10:01 PM
$QNTM Good to see you old friend Shall we have tea? 🫖 你喜欢恰我喜欢宁夏
0 · Reply
PivotalSaints
PivotalSaints May. 26 at 9:59 PM
$QNTM Ok
0 · Reply
ShadowSnake
ShadowSnake May. 26 at 9:56 PM
$QNTM why is this filling the quantum index? It’s a biotech company… 🤦‍♂️
0 · Reply
Ginelle2424
Ginelle2424 May. 26 at 8:40 PM
$QNTM that was spicy, time to buy more
0 · Reply
gloryb
gloryb May. 26 at 8:14 PM
$QNTM what a rug pull that was today
1 · Reply
Fll1225
Fll1225 May. 26 at 8:05 PM
$QNTM got dragged down with all quantum stocks today. Nothing has changed. News imbound
0 · Reply
PivotalSaints
PivotalSaints May. 26 at 7:53 PM
$QNTM Ok
0 · Reply
Wearewhowethought
Wearewhowethought May. 26 at 7:40 PM
$GNS $QNTM Its not coincidnece that these 2 stocks all got algo murdered today Its all pre programmed
0 · Reply
Wearewhowethought
Wearewhowethought May. 26 at 5:13 PM
$QNTM $GNS $FABC so easy to see
0 · Reply
James23db
James23db May. 26 at 4:36 PM
$QNTM holy moly
0 · Reply
Arcides
Arcides May. 26 at 4:35 PM
$QNTM
0 · Reply
Chizzle97
Chizzle97 May. 26 at 4:12 PM
$QNTM Flush = Buy time
0 · Reply
FickleFin
FickleFin May. 26 at 3:38 PM
$QNTM still a shit company. All talk. Nothing comes to fruition. Pump n dump. If you look at their history they don't have the best rap sheet. Financials, lawsuits, broken promises and change of direction(s) Hence the name change to Quantum. Anyone bullish is just ignorant or it's just the same person different alias. Guaranteed promise.
0 · Reply
Wearewhowethought
Wearewhowethought May. 26 at 3:33 PM
$QNTM $GNS $FABC Systematic shorting of micrro caps taking place by jane street, virtu and citadel today. no news on any company just system wide algo shorting groups.
0 · Reply
rockitpicks
rockitpicks May. 26 at 3:19 PM
$QNTM Another shake out of short term traders. I like it. Keep bleeding them out, then it jumps to 20.00
1 · Reply
Wearewhowethought
Wearewhowethought May. 26 at 3:15 PM
$GNS $QNTM
0 · Reply